ArticleFrontiers in physiology2025
Machine learning model for detecting masked hypertension in young adults.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Introduction: Cardiovascular disease (CVD) remains the leading global cause of mortality, with hypertension (HT) being a significant contributor, responsible for 56% of CVD-related deaths. Masked hypertension (MHT), a condition where patients exhibit normotensive blood pressure (BP) in clinical settings but elevated BP in out-of-clinic measurements, poses an elevated risk for cardiovascular complications and often goes undiagnosed. Current diagnostic methods, such as ambulatory BP monitoring (ABPM) and home BP monitoring (HBPM), have limitations in feasibility and accessibility. Methods: This study aimed to address these challenges by leveraging machine learning (ML) models to predict MHT based on clinical data from a single outpatient visit. Utilizing a dataset from the African-PREDICT study, which included comprehensive clinical, biomarker, body composition, and physical activity data from a young, healthy cohort (aged 20-30 years) in South Africa, we developed a predictive framework for MHT detection. Results: The ML models demonstrated the potential to enhance early identification and treatment of MHT, reducing reliance on resource-intensive methods like ABPM. Specifically, we found that utilizing a Least Absolute Shrinkage and Selection Operator (LASSO) feature selection method with an extreme gradient boosting model had an accuracy of 0.83 and a ROC AUC score of 0.86 while relying predominantly on four features: systolic blood pressure, body weight, left ventricular mass at systole, and circulating levels of dehydroepiandrosterone sulfate. Discussion: This approach could enable targeted interventions, particularly in resource-limited settings, thereby mitigating the progression of MHT and its associated risks. These findings underscore the importance of integrating advanced computational techniques into clinical practice to address global health challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.